The possible reason was that activation of CD8+ T cells in response to PD-1 blockade induced a PD-L1/NLRP3 inflammasome signaling cascade that resulted in the recruitment of PMN-MDSC into the tumor, thus inhibited the resulting anti-tumor immune response [89]. The gene discussed is CD8A; the disease is neoplasm.